Leadership: Page 20

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Acquisition with 20/20 Vision

    Is your talent strategy in focus for the year 2020?   The global life science industry faces significant challenges due to geo-political unrest, evolving regulatory controls, the aging workforce, and heightened public awareness around the cost of drugs and overall healthcare expenditures. Simulta...

    By Kevin Duffy • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    EEG Meets Cloud Computing

    A 2011 report from the Tufts Center for the Study of Drug Development suggests that CNS trials are far more complex and costly for pharmaceutical companies to develop than other medicines. Compounds for CNS drugs spend about 8.1 years in clinical testing and 1.9 years in the regulatory process. I...

    By Simon Griffin • June 1, 2017
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Evolution of Clinical Data Management Through Cloud Computing

    Rapid advances in technology are fundamentally changing the role of the data manager. Don’t worry: robots aren’t taking over. But, cloud computing is transforming the way we conduct clinical trials, and massive computing power is enabling analytics and machine learning to become a more integral p...

    By Mike Capone • June 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Philanthropy: Beyond the Numbers

    Pharmaceutical companies — and the industry as a whole — are at the top of many lists in terms of charitable giving, philanthropy, and corporate responsibility. Over the years, pharma has repeatedly been named as a top industry corporate donor, rivaled only by the finance industry. The Reputation...

    By PharmaVoice Team • May 1, 2017
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool John Demaree Astellas Promotes VP of Oncology Marketing in the Americas Region Astellas has promoted John Demaree to VP, oncology marketing, Astellas Americas. In this role, Mr. Demaree is leading Astellas’ oncology marketing team in promotion of in-market products, preparation for ne...

    By PharmaVoice Team • Oct. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Calendar

    Coming Attractions Join a distinguished panel of world-class innovators at the 2nd annual PharmVOICE 100 Celebration, September 15, to discuss how companies can meet the challenges of today’s competitive marketplace by creating a culture of innovation, how to remove the barriers to sustainable su...

    By PharmaVoice Team • Sept. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool Joseph Devaney Astellas Names VP, Government Affairs and Policy Astellas has appointed Joseph Devaney as VP, government affairs and policy, Americas.  Based in Astellas’ Washington, D.C., office, Mr. Devaney is responsible for leading Astellas’ government Affairs and Policy team and d...

    By PharmaVoice Team • Sept. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool Maria Garrigan Eisai Appoints Regulatory VP Eisai, the U.S. pharmaceutical subsidiary of Eisai Co., has appointed Maria Garrigan, as VP, global regulatory strategy for the oncology business group (OBG). In this role, Ms. Garrigan is responsible for leading the oncology regulatory affa...

    By PharmaVoice Team • Aug. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers & Scientists

    Cynthia M. Dukes Title: VP, Global Project Management Company: ICON Clinical Research Education: Baylor College of Medicine Family: Husband, three children Awards/Honors: One of the world’s Most Influential People in Vaccines, Vaccine Nation, 2014; Distinguished Alumni Award, Baylor College of Me...

    By PharmaVoice Team • Aug. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Mentors

    Catherine Angell Sohn, Pharm.D. Title: President Company: Sohn Health Strategies LLC Education: Certificate of Professional Development, The Wharton School, University of Pennsylvania; Doctor of Pharmacy, University of California, San Francisco Family: Mother and father, Vincent and Margaret Ange...

    By PharmaVoice Team • Aug. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Sam Anwar Title: VP, Engineering Company: eClinical Solutions Education: Engineering, Ain Shams University Family: Wife, Inas Dawoud, who has been with him every step of the way; parents, whose hard work helped him to become the person he is today Hobbies: Photography, playing soccer, swimming Bu...

    By PharmaVoice Team • Aug. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    First Jobs

    What was their first job? They may be industry stars today, but many of our PharmaVOICE 100 started out working like everyone else.                                                                Download PDF

    By PharmaVoice Team • Aug. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Challenges Facing Pharmaceutical Leaders

    The pharmaceutical industry is at an unprecedented time in its evolution. Our PharmaVOICE 100 say the shifting influences of the patient, the payer, and technology are changing how medicines are developed and how care is delivered. The convergence of mobile technologies, diagnostics, and personal...

    By PharmaVoice Team • Aug. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool Bob Chib Cassie Hogenkamp Astellas Announces Key Leadership Appointments Astellas has named Bob Chib and Cassie Hogenkamp to key leadership roles within its corporate development function to advance the strategic capabilities of Astellas’ Americas operations and further strengthen the...

    By PharmaVoice Team • June 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    BioTech pool Amy Fix Dr. Louis Fries III Dr. Glenn Gregory Novavax Announces Management Promotion Novavax, a clinical-stage vaccine company focused on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants, has made several promotions. Amy Fix has bee...

    By PharmaVoice Team • May 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biopharma pool Rowena Choudrie Kevin Zikaras Actinium Pharmaceuticals Adds to Product Development and Clinical Research Teams Actinium Pharmaceuticals, a biopharmaceutical company developing innovative, targeted payload immunotherapeutics for the treatment of advanced cancers, has appointed Rowen...

    By PharmaVoice Team • April 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Creating a Culture of Innovation

    The culture of an organization, defined by top leadership, along with the personnel and resources allocated to new ideas, sets the tone for innovation. According to McKinsey, there are eight essential attributes — aspire, choose, discover, evolve, accelerate, scale, extend, and mobilize — that ar...

    By PharmaVoice Team • April 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovation Financing, Venture Capital, and more

    For smaller companies, the ability to find funding and form alliances is the key to continuing research on innovative new medicines. For other companies, venture capital plays a huge role in financing. But some companies are also looking at alternative ways to fund their research, including publi...

    By PharmaVoice Team • April 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biopharma pool Mark Alles Dr. Jacqualyn Fouse Bob Hugin Scott Smith Celgene Strengthens Leadership Team Celgene has made several organizational changes to strengthen its leadership team and position the company for long-term growth. Mark Alles has been promoted to CEO. Mr. Alles is a three-decade...

    By PharmaVoice Team • March 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Addressing the Gender Gap Laurie Cooke, CEO of the Healthcare Businesswomen’s Association, talks about the importance of gender diversity and the HBA’s role in moving the needle. PV: The HBA recently updated its mission to include addressing the gender gap that exists within the executive leaders...

    By Laurie Cooke • March 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Talent Optimization

    According to PwC’s 2015 US CEO survey, CEOs say they want a workforce that reflects an increasingly diverse customer base that’s more global and tech-savvy. They are also creating new models to pave a new path forward. They are using data-supported talent strategies; fostering innovation-friendly...

    By Taren Grom • March 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool Paris Panayiotopoulos Ariad Names President and CEO Paris Panayiotopoulos has been appointed president and CEO of Ariad, an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. Most recently, Mr. Panayiotopoulos was presi...

    By PharmaVoice Team • Feb. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool Paul Biondi Bristol-Myers Squibb Appoints Senior VP, Head of Business Development Bristol-Myers Squibb has appointed Paul Biondi as senior VP, head of business development. In this role, he is responsible for leading the development of strategic partnerships and pursuing scientific in...

    By PharmaVoice Team • Jan. 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma pool Dr. James Bradner Novartis Institutes for BioMedical Research Appoints President Dr. James (Jay) Bradner, physician-scientist from Dana-Farber Cancer Institute and Harvard Medical School, has been appointed president of the Novartis Institutes for BioMedical Research (NIBR) and a memb...

    By PharmaVoice Team • Nov. 15, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Reputation: Solving the Reputation Challenge

    There is no denying that the pharmaceutical industry has a problem. The industry continues to field questions about its pricing, off-label prescribing, and salesforce practices. These forces culminated this fall when Turing CEO Martin Shkreli — dubbed the most hated man in America at the time — r...

    By Denise Myshko • Nov. 15, 2015